Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial

OBJECTIVE: To compare the efficacy of Food and Drug Administration recommended dosing of nicardipine versus labetalol for the management of hypertensive patients with signs and/or symptoms (S/S) suggestive of end-organ damage (EOD). DESIGN: Secondary analysis of the multicentre prospective, randomis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannon, Chad M, Levy, Phillip, Baumann, Brigitte M, Borczuk, Pierre, Chandra, Abhinav, Cline, David M, Diercks, Deborah B, Hiestand, Brian, Hsu, Amy, Jois, Preeti, Kaminski, Brian, Nowak, Richard M, Schrock, Jon W, Varon, Joseph, Peacock, W Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612758/
https://www.ncbi.nlm.nih.gov/pubmed/23535700
http://dx.doi.org/10.1136/bmjopen-2012-002338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612758/
https://www.ncbi.nlm.nih.gov/pubmed/23535700
http://dx.doi.org/10.1136/bmjopen-2012-002338

Ejemplares similares